Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

Suntory presents SUN-C5174, a 5-HT2 antagonist with potent antiplatelet activity

March 25, 1999

Novel thrombin inhibitor series from 3-D discussed at ACS meeting

March 25, 1999

Bristol-Myers Squibb announces Spanish launch of antiplatelet drug

March 25, 1999

ACS highlights: 3-D progresses in development of new class of thrombin inhibitors

March 24, 1999

Texas Biotechnology resubmits Novastan NDA

March 24, 1999

Another anticoagulant series presented by DuPont at the ACS meeting

March 23, 1999

ACS highlights: new noncovalent thrombin inhibitors described by Merck & Co.

March 23, 1999

DuPont presents potent and selective factor Xa inhibitors

March 23, 1999

Japan is country of first launch for Yamanouchi's second-generation t-PA

March 23, 1999

Profile of CS-747, a novel antiplatelet agent from Sankyo and Ube

March 22, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.